Free Trial

China Intl Cap Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at China Intl Cap. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from China Intl Cap's equity research team. MarketBeat is not affiliated with or endorsed by China Intl Cap.

  • Updated 4/6/2026
Average Return
00.00% 12-Month ROI
Total Ratings
1 Last 12 Months
Buy Ratings
1 Last 12 Months
Sell Ratings
0 Last 12 Months
Companies Covered
1 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
$22.03
+0.0%
4/6/2026 UpgradeStrong-BuyView details for China Intl Cap rating of Ascentage Pharma Group International (NASDAQ:AAPG) on 4/6/2026

MarketBeat's community ratings are surveys of what our community members think about China Intl Cap and other research firms in the last 90 days. Vote "Outperform" if you believe China Intl Cap's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe China Intl Cap's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.5out of 5 (last 90 days)
2.5 of 5 stars
OUTPERFORM VOTES
39 Believe will outperform S&P 500
UNDERPERFORM VOTES
39 Believe will underperform S&P 500

China Intl Cap Stock Coverage by Sector

China Intl Cap concentrates its research most heavily in Medical (100.0%). The chart below shows how China Intl Cap's 1 rated company is distributed across all 1 sector it covers.

China Intl Cap - Frequently Asked Questions

China Intl Cap's analysts currently have buy-equivalent ratings on 1 companies. Recent upgrades to buy include Ascentage Pharma Group International.

China Intl Cap has the deepest coverage in Medical (100.0% of rated companies).

China Intl Cap issued 1 ratings over the last 12 months across 1 companies — an average of roughly 0 rating actions per month. These include upgrade. MarketBeat tracks every rating change as it's published so you can see the most current China Intl Cap analyst actions.